アブストラクト
Japanese
| Title | 当院における新生児重症黄疸に対する交換輸血30例の検討 |
|---|---|
| Subtitle | 資料 |
| Authors | 田中伸久1), 新井菜津子1) |
| Authors (kana) | |
| Organization | 1)群馬県立小児医療センター検査課 |
| Journal | 医学検査 |
| Volume | 70 |
| Number | 3 |
| Page | 566-570 |
| Year/Month | 2021 / 7 |
| Article | 報告 |
| Publisher | 日本臨床衛生検査技師会 |
| Abstract | 「要旨」交換輸血(exchange transfusion; ET)は, 新生児の重症黄疸にとって有用な治療法である. 2011年から2020年までに当院で行われた新生児の交換輸血事例についてまとめた. 最近10年間に当院で行われた新生児のET 56例のうち, 重症黄疸を理由とした30例を対象に, 診療録のデータから後方視的調査を行った. ET例の83.3%(25/30)が正期産児であり, 86.7%(26/30)が他施設からの搬入であった. 30例のうち母児間のABO不適合と診断されたのは10例で, そのうち母O型, 児B型の組み合わせが8例であった. ABO不適合10例における直接抗グロブリン試験の陽性率は60.0%(6/10)であった. ETに続発して血小板減少など一時的な検査値の異常がみられたが, 死亡例はもちろんのこと臨床的問題の記載は確認されなかった. |
| Practice | 医療技術 |
| Keywords | 交換輸血, 新生児重症黄疸, アンバウンドビリルビン, ABO血液型不適合, 新生児, exchange transfusion, severe neonatal jaundice, unbound bilirubin, ABO incompatibility, newborn |
English
| Title | Report of cases of 30 infants with exchange transfusion for severe neonatal jaundice in Gunma Children's Medical Center |
|---|---|
| Subtitle | Materials |
| Authors | Nobuhisa TANAKA1), Natsuko ARAI1) |
| Authors (kana) | |
| Organization | 1)Department of Clinical Laboratory, Gunma Children's Medical Center |
| Journal | Japanese Journal of Medical Technology |
| Volume | 70 |
| Number | 3 |
| Page | 566-570 |
| Year/Month | 2021 / 7 |
| Article | Report |
| Publisher | Japanese Association of Medical Technologists |
| Abstract | [Summary] Exchange transfusion (ET) is an effective treatment for severe neonatal jaundice. In this study, we reviewed the cases of infants with ET in Gunma Children's Medical Center from 2011 - 2020. Of the total of 56 infants with ETs, 30 with severe neonatal jaundice were identified. Clinical and laboratory data were collected retrospectively from their medical records. Most infants who underwent ET were full term (gestational age 37 - 41 weeks) (25/30; 83.3%) and were admitted to our hospital after birth (26/30; 86.7%). Out of these 30 infants, 10 were diagnosed as having ABO incompatibility. In eight of these 10 infants, the mothers' blood group was O and the infants' blood group was B. Six of these infants (6/10; 60.0%) showed positive results of the direct antiglobulin test. The identified adverse events secondary to ET included thrombocytopenia and others. The majority of adverse events associated with ET were laboratory abnormalities that were asymptomatic. No deaths or complications were reported arising from the treatment. |
| Practice | Medical technology |
| Keywords | exchange transfusion, severe neonatal jaundice, unbound bilirubin, ABO incompatibility, newborn |
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
参考文献
- 1) 船戸 正久 : 「新生児溶血性疾患の病態と治療」, 日輸血会誌, 2002; 47: 837-844.
- 2) 川上 義 : 「交換輸血療法」, 小児外科, 2003; 35: 178-181.
- 3) Gibson BE et al.: "Transfusion guidelines for neonates and older children," Br J Haematol, 2004; 124: 433-453.
- 4) 小山 典久, 他 : 「豊橋市民病院新生児医療センターにおける交換輸血の実態-交換輸血の問題点・注意点に関する考察-」, 日輸血会誌, 2003; 49: 63-67.
- 5) 小山 典久, 他 : 「新生児の交換輸血およびその使用血液に関する実態調査」, 日新生児成育医学会誌, 2020; 32: 138-143.
残りの15件を表示する
- 6) 中村 肇, 他 : 「早産児の黄疸管理の現状と課題」, 日未熟児新生児会誌, 2014; 26: 57-66.
- 7) 森岡 一朗, 他 : 「我が国の超早産児に対する黄疸管理と治療の現状」, 日新生児成育医会誌, 2015; 27: 95-100.
- 8) 新生児医療連合会 : 「III ハイリスク児 Dハイリスク児の基本的管理 4.治療」, NICUマニュアル第5版, 219, 市場 博幸, 他(編), 金原出版, 東京, 2014.
- 9) Duan L et al.: "A single-center experience on exchange transfusion therapy in 123 full-term cases of severe neonatal hyperbilirubinemia in Wuhan," J Matern Fetal Neonatal Med, 2021; 34: 466-472.
- 10) Hakan N et al.: "Exchange transfusion tbr neonatal hyperbilirubinemia: An 8-year single center experience at a tertiary neonatal intensive care unit in Turkey," J Matern Fetal Neonatal Med, 2015; 28: 1537-1541.
- 11) Bujandric N, Grujic J: "Exchange transfusion for severe neonatal hyperbilirubinemia: 17 years' experience from Vojvodina, Serbia," Indian J Hematol Blood Transfus, 2016; 32: 208-214.
- 12) Davutoglu M et al.: "The etiology of severe neonatal hyperbilirubinemia and complications of exchange transfusion," Turk J Pediatr, 2010; 52: 163-166.
- 13) Yu C et al.: "Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011," PLoS One, 2017; 12: e0179550.
- 14) 宮崎 澄雄, 他 : 「周産期医療の新技術 新生児編 高ビリルビン血症に対するガンマグロブリン療法」, 周産期医学, 1995; 25: 983-986.
- 15) Osborn LM et al.: "Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility," Pediatrics, 1984; 74: 371-374.
- 16) 浮田 昌彦, 他 : 「ABO式血液型不適合妊娠における新生児赤血球の直接グロブリン試験陽性の意義について-IgGサブクラスの検討-」, 日輸血会誌, 1988; 34: 601-606.
- 17) 小山 典久, 他 : 「赤血球濃厚液, 新鮮凍結血漿, 濃厚血小板を混合した血液の性状と交換輸血使用血としての適格性に関する検討」, 日新生児成育医会誌, 2016; 28: 77-83.
- 18) Ballot DE, Rugamba G: "Exchange transfusion for neonatal hyperbilirubinemia in Johannesburg, South Africa, from 2006 to 2011," Int Sch Res Notices, 2016; 2016: 1268149.
- 19) Gharehbaghi MM, Hosseinpour SS: "Exchange transfusion in neonatal hyperbilirubinemia: A comparison between citrated whole blood and reconstituted blood," Singapore Med J, 2010; 51: 641-644.
- 20) Malla T, Rugamba G: "A prospective study on exchange transfusion in neonatal unconjugated hyperbilirubinemia in a tertiary care hospital," Nepal Kathmandu Univ Med J, 2017; 13: 102-108.
